Xtant Medical Holdings (XTNT) Receivables - Other (2010 - 2011)

Xtant Medical Holdings' (XTNT) quarterly Receivables - Other came in at $675098.0 in Q3 2011, up 1.34% on a QoQ basis from $666173.0 in Q2 2011.

Xtant Medical Holdings (XTNT) Receivables - Other (2010 - 2011) Analysis & Trends

Xtant Medical Holdings (XTNT) has 2 years of Receivables - Other data on file, last reported at $675098.0 in Q3 2011.

On a quarterly basis, Receivables - Other changed N/A year-over-year to $675098.0 in Q3 2011; TTM through Sep 2011 was $675098.0, a N/A change from a year earlier, with the FY2010 full-year figure at $613034.0, changed N/A from the prior year.
Receivables - Other for Q3 2011 stood at $675098.0, up from $666173.0 in the prior quarter.
Over the last five years, Receivables - Other for XTNT reached as high as $675098.0 in Q3 2011 and fell as low as $613034.0 in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Xtant Medical Holdings	5.69 Mn	-11.63 Mn	17.75 Mn

Download Data